Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1 9Phase 1/2 4Phase NA 3Phase EARLY_PHASE1 2Phase 2/3 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Prostatic Neoplasms 9Glioma 7Brain Neoplasms 6Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Neoplasm Metastasis 4Sarcoma 3Melanoma 3Lung Neoplasms 3Glioblastoma 3Colonic Neoplasms 3Carcinoma, Hepatocellular 3Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroendocrine Tumors 2Neuroblastoma 2Lymphoma, Large B-Cell, Diffuse 2Laryngeal Neoplasms 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2von Hippel-Lindau Disease 1Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Rhabdomyosarcoma 1

Interventions

Cyclophosphamide 4Rituximab 3Vincristine 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Immunotherapy, Adoptive 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Doxorubicin 2tisagenlecleucel 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1oblimersen 1ibritumomab tiuxetan 1duvelisib 1Surveys and Questionnaires 1Sugars 1Specimen Handling 1Radiation 1Pemetrexed 1Nivolumab 1NVP-BKM120 1Microarray Analysis 1Methotrexate 1Loratadine 1Leukapheresis 1Immunohistochemistry 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma, Large B-Cell, Diffuse × Magnetic Resonance Spectroscopy × Clear all
NCT05800405 2026-02-04

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

City of Hope Medical Center

Phase EARLY_PHASE1 Recruiting
9 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02405078 2022-10-28

Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
35 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡